PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
The invention relates to biotechnology. The claimed agent can be used for the prevention of SARS- CoV-2. There is created a pharmaceutical agent, which contains component (1), comprising an agent in the form a genome of recombinant human adenovirus serotype (26), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant human adenovirus serotype (5), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3. Further, there is created a pharmaceutical agent, which contains component 1, comprising an agent in the form a genome of recombinant human adenovirus serotype (26), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant simian adenovirus serotype (25), wherein with a placed expression cassette selected from SEQ ID NO: 4, SEQ ID NO: 2, SEQ ID NO: 3. Furthermore, there is created a pharmaceutical agent, which contains component 1, comprising an agent in the form a genome of recombinant simian adenovirus serotype (25), wherein with a placed expression cassette selected from SEQ ID NO: 4, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant human adenovirus serotype (5), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Europäisches Patentamt - (2021) vom: 22. Apr. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ZUBKOVA OLGA VADIMOVNA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-04-22, Last update posted on www.tib.eu: 2023-06-08, Last updated: 2023-06-16 |
|---|
| Patentnummer: |
WO2021076010 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA011315156 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA011315156 | ||
| 003 | DE-627 | ||
| 005 | 20230616045403.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210601s2021 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA011315156 | ||
| 035 | |a (EPA)WO2021076010 | ||
| 035 | |a (EPA)72421627 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ZUBKOVA OLGA VADIMOVNA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2021-04-22, Last update posted on www.tib.eu: 2023-06-08, Last updated: 2023-06-16 | ||
| 520 | |a The invention relates to biotechnology. The claimed agent can be used for the prevention of SARS- CoV-2. There is created a pharmaceutical agent, which contains component (1), comprising an agent in the form a genome of recombinant human adenovirus serotype (26), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant human adenovirus serotype (5), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3. Further, there is created a pharmaceutical agent, which contains component 1, comprising an agent in the form a genome of recombinant human adenovirus serotype (26), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant simian adenovirus serotype (25), wherein with a placed expression cassette selected from SEQ ID NO: 4, SEQ ID NO: 2, SEQ ID NO: 3. Furthermore, there is created a pharmaceutical agent, which contains component 1, comprising an agent in the form a genome of recombinant simian adenovirus serotype (25), wherein with a placed expression cassette selected from SEQ ID NO: 4, SEQ ID NO: 2, SEQ ID NO: 3, and which also contains component (2), comprising an agent in the form a genome of recombinant human adenovirus serotype (5), wherein with a placed expression cassette selected from SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3. | ||
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a bio | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a OZHAROVSKAIA TATIANA ANDREEVNA |4 aut | |
| 700 | 0 | |a DOLZHIKOVA INNA VADIMOVNA |4 aut | |
| 700 | 0 | |a POPOVA OLGA |4 aut | |
| 700 | 0 | |a SHCHEBLIAKOV DMITRII VIKTOROVICH |4 aut | |
| 700 | 0 | |a GROUSOVA DARIA MIKHAILOVNA |4 aut | |
| 700 | 0 | |a DZHARULLAEVA ALINA SHAHMIROVNA |4 aut | |
| 700 | 0 | |a TUKHVATULIN AMIR ILDAROVICH |4 aut | |
| 700 | 0 | |a TUKHVATULINA NATALIA MIKHAILOVNA |4 aut | |
| 700 | 0 | |a SHCHERBININ DMITRII NIKOLAEVICH |4 aut | |
| 700 | 0 | |a ESMAGAMBETOV ILIAS BULATOVICH |4 aut | |
| 700 | 0 | |a TOKARSKAYA ELIZAVETA ALEXANDROVNA |4 aut | |
| 700 | 0 | |a BOTIKOV ANDREI GENNADEVICH |4 aut | |
| 700 | 0 | |a EROXOVA ALINA SERGEEVNA |4 aut | |
| 700 | 0 | |a IZHAEVA FATIMA MAGOMETOVNA |4 aut | |
| 700 | 0 | |a SEMIKHIN ALEKSANDR SERGEEVICH |4 aut | |
| 700 | 0 | |a BORISEVICH SERGEY VLADIMIROVICH |4 aut | |
| 700 | 0 | |a NARODITSKIY BORIS SAVELIEVICH |4 aut | |
| 700 | 0 | |a LOGUNOV DENIS YURYEVICH |4 aut | |
| 700 | 0 | |a GINTSBURG ALEKSANDR LEONIDOVICH |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 22. Apr. |
| 773 | 1 | 8 | |g year:2021 |g day:22 |g month:04 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72421627/publication/WO2021076010A1?q=WO2021076010 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2021 |b 22 |c 04 |
| 951 | |a AR | ||
| 952 | |j 2021 |b 22 |c 04 | ||